GSK to pull its OTC codeine

white capsules, that resemble OMG Slim capsules
GSK has announced that it will pull its codeine-containing OTCs, as the Guild talks accessibility with the TGA GSK issued a statement advising that it will not move its S3 codeine range to prescription only next year. "We (GSK) respect the delegate’s decision to upschedule codeine-containing analgesic from 1st February, 2018, which was based on

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Start 7CPA negotiations now: Catherine King
Next No S3 ad decision for at least a year